These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Carcinoembryonic antigen (CEA) in carcinoma of the upper urinary tract and bladder. Immunohistochemical study]. Lanzafame S, Puzzo L, Di Naso C, Di Marco G, Ranno S, Minardi G. Pathologica; 1986 May 26; 78(1056):451-8. PubMed ID: 3302887 [No Abstract] [Full Text] [Related]
6. Detection of antigens on transitional cell carcinoma with a xenogeneic antiserum. Bloom ET. Natl Cancer Inst Monogr; 1978 Dec 26; (49):57-8. PubMed ID: 86168 [Abstract] [Full Text] [Related]
7. Specific red cell adherence test applied to tumors of ureter and renal pelvis. Gruber MB, Becker SN, Warren MM, Rambo MJ, Davis CP. Urology; 1982 Apr 26; 19(4):361-5. PubMed ID: 7072026 [Abstract] [Full Text] [Related]
9. Staphylococcal protein A assay for detection of antibody directed at renal cancer cells. Leblanc PA, Taffet SM, Fried FA, Avis FP. J Urol; 1979 Jun 26; 121(6):724-7. PubMed ID: 458941 [Abstract] [Full Text] [Related]
11. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG. Lange PH. Natl Cancer Inst Monogr; 1978 Dec 26; (49):343-5. PubMed ID: 748791 [Abstract] [Full Text] [Related]
12. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary. Perlmann P, Troye M, Pape G, Blomgren H, Johansson B. Urol Res; 1978 Dec 26; 6(4):207-9. PubMed ID: 741533 [Abstract] [Full Text] [Related]
13. A 51chromium isotope release assay for detecting cytotoxicity to human bladder carcinoma. O'Toole C. Int J Cancer; 1977 Mar 15; 19(3):324-31. PubMed ID: 844912 [Abstract] [Full Text] [Related]
14. Humoral cytotoxicity in human renal cell carcinoma. Hakala TR, Castro AE, Elliott AY, Fraley EE. Invest Urol; 1974 Mar 15; 11(5):405-10. PubMed ID: 4592928 [No Abstract] [Full Text] [Related]
16. Disease-related lymphocyte cytotoxicity in rats bearing transitional cell carcinoma of bladder. Effect of immunomodulators. Moroz C, Madgar I, Twig S, Lindner A, Many M. Int J Cancer; 1982 Jun 15; 29(6):667-72. PubMed ID: 6980847 [Abstract] [Full Text] [Related]
17. The use of the red cell surface antigen to predict the malignant potential of transitional cell carcinoma of the ureter and renal pelvis. Hall L, Faddoul A, Saberi A, Edson M. J Urol; 1982 Jan 15; 127(1):23-5. PubMed ID: 7057496 [Abstract] [Full Text] [Related]
19. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera. Schneider MU, Troye M, Paulie S, Perlmann P. Int J Cancer; 1980 Aug 15; 26(2):185-92. PubMed ID: 7203712 [Abstract] [Full Text] [Related]
20. Use of monoclonal antibodies for the localization of tissue isoantigens A and B in transitional cell carcinoma of the upper urinary tract. Chapman CM, Allhoff EP, Proppe KH, Prout GR. J Histochem Cytochem; 1983 Apr 15; 31(4):557-61. PubMed ID: 6827085 [Abstract] [Full Text] [Related] Page: [Next] [New Search]